| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |